Published in J Clin Microbiol on November 17, 2010
Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J (2011) 1.29
Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis. J Bacteriol (2012) 1.00
Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother (2013) 0.98
Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis. PLoS One (2012) 0.93
Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center. PLoS One (2016) 0.83
Longitudinal analysis of the temporal evolution of Acinetobacter baumannii strains in Ohio, USA, by using rapid automated typing methods. PLoS One (2012) 0.79
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Complex Isolates from Patients that were Injured During the Eastern Ukrainian Conflict. Eur J Microbiol Immunol (Bp) (2016) 0.78
Phenotypic and genotypic changes over time and across facilities of serial colonizing and infecting Escherichia coli isolates recovered from injured service members. J Clin Microbiol (2014) 0.77
Clinico-epidemiological nature and antibiotic susceptibility profile of Acinetobacter species. Pak J Med Sci (2013) 0.75
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma (1974) 47.36
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control (2008) 24.70
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol (2007) 10.18
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents (2006) 7.58
The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis (2006) 7.29
Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother (2006) 4.80
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett (2006) 4.73
Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect (2007) 4.55
From the national institutes of health. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the enterobacteriaceae and other bacteria. J Infect Dis (1983) 4.27
The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One (2010) 4.19
Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol (1996) 3.52
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol (2004) 2.81
An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis (2007) 2.80
Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol (2001) 2.49
Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol (2006) 2.49
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care (2006) 2.07
Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol (2004) 1.93
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J Antimicrob Chemother (2004) 1.72
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother (2008) 1.71
Acinetobacter skin colonization of US Army Soldiers. Infect Control Hosp Epidemiol (2006) 1.57
Trauma-related infections in battlefield casualties from Iraq. Ann Surg (2007) 1.49
Inflammatory biomarkers in combat wound healing. Ann Surg (2009) 1.45
Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect (2002) 1.41
Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol (2006) 1.41
Infectious diseases during wartime. Curr Opin Infect Dis (2005) 1.31
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int J Antimicrob Agents (2009) 1.30
Typing of Acinetobacter calcoaceticus strains isolated from hospital patients by cell envelope protein profiles. Epidemiol Infect (1987) 1.23
Blood transfusion is associated with infection and increased resource utilization in combat casualties. Am Surg (2006) 1.15
Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains. J Antimicrob Chemother (2007) 1.13
Bacteria recovered from patients admitted to a deployed U.S. military hospital in Baghdad, Iraq. Mil Med (2006) 1.11
Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001. Clin Microbiol Infect (2006) 1.08
Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control. J Hosp Infect (2008) 1.05
Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker. Clin Infect Dis (2008) 0.96
Antibiotic resistance determinants in Acinetobacter spp and clinical outcomes in patients from a major military treatment facility. Am J Infect Control (2009) 0.94
Association of bacterial colonization at the time of presentation to a combat support hospital in a combat zone with subsequent 30-day colonization or infection. Mil Med (2009) 0.93
Gram-negative bacteria from patients seeking medical advice in Stockholm after the tsunami catastrophe. Scand J Infect Dis (2006) 0.90
Perioperative blood transfusion in combat casualties: a pilot study. J Trauma (2009) 0.85
Can Escherichia coli be used as an indicator organism for transmission events in hospitals? Eur J Clin Microbiol Infect Dis (2008) 0.79
The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One (2010) 4.19
Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol (2005) 3.68
Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol (2004) 2.81
Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol (2005) 2.75
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Arch Intern Med (2009) 2.16
Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology (2009) 2.11
Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J (2013) 2.09
Impact of incident venous thromboembolism on risk of arterial thrombotic diseases. Circulation (2013) 2.04
Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol (2004) 2.04
Epidemiology of cancer-associated venous thrombosis. Blood (2013) 2.00
Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol (2004) 1.93
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med (2013) 1.91
Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol (2004) 1.73
Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J Clin Microbiol (2006) 1.71
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother (2008) 1.71
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Naturally transformable Acinetobacter sp. strain ADP1 belongs to the newly described species Acinetobacter baylyi. Appl Environ Microbiol (2006) 1.59
Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol (2009) 1.56
Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am J Respir Crit Care Med (2005) 1.56
The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol (2008) 1.50
The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood (2013) 1.47
[Suspicion of pulmonary embolism: added value of CT depends on patient characteristics and referring individual]. Ned Tijdschr Geneeskd (2012) 1.45
The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS One (2012) 1.39
Fluid loss does not explain coagulation activation during air travel. Thromb Haemost (2008) 1.38
A case of thrombosis at high altitude. Thromb Haemost (2005) 1.38
Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol (2005) 1.37
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab (2013) 1.32
Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens. Int J Syst Evol Microbiol (2003) 1.31
Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PLoS One (2010) 1.27
Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I. Antimicrob Agents Chemother (2011) 1.27
Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different European hospitals. Res Microbiol (2004) 1.21
Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med (2008) 1.19
CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol (2009) 1.18
Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986. Int J Syst Evol Microbiol (2008) 1.17
Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol (2010) 1.16
Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica (2009) 1.15
Molecular and phenotypic characterization of Acinetobacter strains able to degrade diesel fuel. Res Microbiol (2011) 1.13
Relationship between the AdeABC efflux system gene content, netilmicin susceptibility and multidrug resistance in a genotypically diverse collection of Acinetobacter baumannii strains. J Antimicrob Chemother (2007) 1.13
Quantification of bias in direct effects estimates due to different types of measurement error in the mediator. Epidemiology (2012) 1.11
RAPD typing of Klebsiella pneumoniae, Klebsiella oxytoca, Serratia marcescens and Pseudomonas aeruginosa isolates using standardized reagents. Clin Microbiol Infect (1999) 1.09
Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol (2009) 1.08
Exploring the evolutionary dynamics of plasmids: the Acinetobacter pan-plasmidome. BMC Evol Biol (2010) 1.08
Pseudomonas putida war wound infection in a US Marine: a case report and review of the literature. J Infect (2008) 1.06
Rapid epidemiological analysis of Acinetobacter strains by Raman spectroscopy. J Microbiol Methods (2005) 1.06
Comparison of Acinetobacter baumannii isolates from United Kingdom hospitals with predominant Northern European genotypes by amplified-fragment length polymorphism analysis. J Clin Microbiol (2004) 1.05
Confounding by Indication: Letter to the Editor. Am J Sports Med (2016) 1.05
Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med (2012) 1.03
Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia. PLoS One (2012) 1.03
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood (2008) 1.01
Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study. PLoS Med (2006) 1.01
Variations in colistin susceptibility among different species of the genus Acinetobacter. J Antimicrob Chemother (2009) 1.01
Characterization of a 2.6 kbp variable region within a class 1 integron found in an Acinetobacter baumannii strain isolated from a horse. J Antimicrob Chemother (2005) 1.00
Repetitive-DNA-element PCR fingerprinting and antibiotic resistance of pan-European multi-resistant Acinetobacter baumannii clone III strains. J Med Microbiol (2005) 1.00
Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost (2011) 1.00
Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood (2012) 0.99
Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme. PLoS One (2013) 0.98
In vitro antifungal efficacy of four irrigants as a final rinse. J Endod (2006) 0.98
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res (2013) 0.97
Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain. Europace (2011) 0.97
Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker. Clin Infect Dis (2008) 0.96
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study. Blood (2010) 0.96
Lack of evidence for "Acinetobacter septicus" as a species different from Acinetobacter ursingii? J Clin Microbiol (2008) 0.94
Genotypic and phenotypic correlations of multidrug-resistant Acinetobacter baumannii-A. calcoaceticus complex strains isolated from patients at the National Naval Medical Center. J Clin Microbiol (2010) 0.94
Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol (2010) 0.94
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study. Br J Haematol (2008) 0.93
Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace (2011) 0.93
Microbial systematics and taxonomy: relevance for a microbial commons. Res Microbiol (2010) 0.92
Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica (2013) 0.92
Draft genome sequence of the hydrocarbon-degrading and emulsan-producing strain Acinetobacter venetianus RAG-1T. J Bacteriol (2012) 0.92
Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol (2008) 0.92
The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. PLoS Med (2007) 0.91
Cardiac device infections are associated with a significant mortality risk. Heart Rhythm (2011) 0.90
Intercenter reproducibility of binary typing for Staphylococcus aureus. J Microbiol Methods (2002) 0.89
Cryo-electron tomography analysis of membrane vesicles from Acinetobacter baumannii ATCC19606 T. Res Microbiol (2013) 0.88
Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey. Infect Genet Evol (2012) 0.87
Influence of gender on ischemic times and outcomes after ST-elevation myocardial infarction. Am J Cardiol (2012) 0.87
Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides. Clin Diagn Lab Immunol (2002) 0.87
Multidrug-resistant Acinetobacter baumannii in veterinary clinics, Germany. Emerg Infect Dis (2011) 0.86
High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Res Microbiol (2007) 0.86
Description of Acinetobacter venetianus ex Di Cello et al. 1997 sp. nov. Int J Syst Evol Microbiol (2009) 0.85
Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization. Antimicrob Agents Chemother (2012) 0.85
Sex difference in risk of second but not of first venous thrombosis: paradox explained. Circulation (2013) 0.85
Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array. J Med Microbiol (2009) 0.85
The spatial QRS-T angle in the Frank vectorcardiogram: accuracy of estimates derived from the 12-lead electrocardiogram. J Electrocardiol (2010) 0.84
High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander? Haematologica (2010) 0.84
Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol (2013) 0.83
A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. Nephrol Dial Transplant (2014) 0.83
Microbiological material exchanges among scientists. Res Microbiol (2010) 0.83
Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function. Circulation (2013) 0.83
Patients with early arthritis consume less alcohol than controls, regardless of the type of arthritis. Rheumatology (Oxford) (2013) 0.82
Multiresistant Staphylococcus epidermidis in a neonatal care unit. Clin Microbiol Infect (1996) 0.82
Pulse wave velocity and flow in the carotid artery versus the aortic arch: effects of aging. J Magn Reson Imaging (2013) 0.82
Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood (2011) 0.82
Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica (2012) 0.82
OXA-23-type imipenem resistance in Acinetobacter baumannii in Hong Kong. Int J Antimicrob Agents (2009) 0.82
Nosocomial bacteremia due to an as yet unclassified acinetobacter genomic species 17-like strain. J Clin Microbiol (2006) 0.81
The genome sequence of the hydrocarbon-degrading Acinetobacter venetianus VE-C3. Res Microbiol (2013) 0.80